Cognitive impairment in nondemented Parkinson's disease
Identifieur interne : 000254 ( Main/Curation ); précédent : 000253; suivant : 000255Cognitive impairment in nondemented Parkinson's disease
Auteurs : Paolo Barone [Italie] ; Dag Aarsland [Norvège] ; David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Jaime Kulisevsky [Espagne] ; Daniel Weintraub [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-12.
English descriptors
Abstract
A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in early‐stage disease and many routine assessment tools lack the sensitivity to detect subtle cognitive dysfunction. Patients with PD and mild CI (MCI) may have a higher risk of developing dementia than cognitively intact PD patients; however, it is not currently known which patients with CI are at increased risk of developing dementia. This review summarizes current knowledge about CI in nondemented PD; it discusses the structural and functional changes associated with CI and addresses areas of unmet needs. We focus on questions that should be addressed in future studies to achieve consensus on its characteristics and definition, pathophysiology, epidemiology, diagnosis and assessment, and treatment and management. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23919
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000301
Links to Exploration step
ISTEX:9A89F0CE3754B0A23F5E7DF5E4712ABC04D69B7ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cognitive impairment in nondemented Parkinson's disease</title><author><name sortKey="Barone, Paolo" sort="Barone, Paolo" uniqKey="Barone P" first="Paolo" last="Barone">Paolo Barone</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University Federico II‐ICD Hermitage, Capodimonte, Naples, Italy, and Schola Medica Salernitana, University of Salerno, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological Sciences, University Federico II‐ICD Hermitage, Capodimonte, Naples, Italy, and Schola Medica Salernitana, University of Salerno</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Psychiatric Division, Stavanger University Hospital and Akerhus University Hospital, University of Oslo, Stavanger, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Psychiatric Division, Stavanger University Hospital and Akerhus University Hospital, University of Oslo, Stavanger</wicri:regionArea></affiliation></author><author><name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University</wicri:regionArea></affiliation></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey</mods:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea></affiliation></author><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name><affiliation wicri:level="1"><mods:affiliation>Neurology Department, Hospital de Sant Pau (IIB Sant Pau), CIBERNED and Autonomous University of Barcelona, Barcelona, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Neurology Department, Hospital de Sant Pau (IIB Sant Pau), CIBERNED and Autonomous University of Barcelona, Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation wicri:level="1"><mods:affiliation>Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9A89F0CE3754B0A23F5E7DF5E4712ABC04D69B7E</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23919</idno><idno type="url">https://api.istex.fr/document/9A89F0CE3754B0A23F5E7DF5E4712ABC04D69B7E/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000301</idno><idno type="wicri:Area/Main/Curation">000254</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cognitive impairment in nondemented Parkinson's disease</title><author><name sortKey="Barone, Paolo" sort="Barone, Paolo" uniqKey="Barone P" first="Paolo" last="Barone">Paolo Barone</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University Federico II‐ICD Hermitage, Capodimonte, Naples, Italy, and Schola Medica Salernitana, University of Salerno, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological Sciences, University Federico II‐ICD Hermitage, Capodimonte, Naples, Italy, and Schola Medica Salernitana, University of Salerno</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Psychiatric Division, Stavanger University Hospital and Akerhus University Hospital, University of Oslo, Stavanger, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Psychiatric Division, Stavanger University Hospital and Akerhus University Hospital, University of Oslo, Stavanger</wicri:regionArea></affiliation></author><author><name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University</wicri:regionArea></affiliation></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey</mods:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea></affiliation></author><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name><affiliation wicri:level="1"><mods:affiliation>Neurology Department, Hospital de Sant Pau (IIB Sant Pau), CIBERNED and Autonomous University of Barcelona, Barcelona, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Neurology Department, Hospital de Sant Pau (IIB Sant Pau), CIBERNED and Autonomous University of Barcelona, Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation wicri:level="1"><mods:affiliation>Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-12">2011-12</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2483">2483</biblScope><biblScope unit="page" to="2495">2495</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">9A89F0CE3754B0A23F5E7DF5E4712ABC04D69B7E</idno><idno type="DOI">10.1002/mds.23919</idno><idno type="ArticleID">MDS23919</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CIND‐PD</term><term>Parkinson's disease</term><term>assessment</term><term>mild cognitive impairment</term><term>symptoms</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in early‐stage disease and many routine assessment tools lack the sensitivity to detect subtle cognitive dysfunction. Patients with PD and mild CI (MCI) may have a higher risk of developing dementia than cognitively intact PD patients; however, it is not currently known which patients with CI are at increased risk of developing dementia. This review summarizes current knowledge about CI in nondemented PD; it discusses the structural and functional changes associated with CI and addresses areas of unmet needs. We focus on questions that should be addressed in future studies to achieve consensus on its characteristics and definition, pathophysiology, epidemiology, diagnosis and assessment, and treatment and management. © 2011 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000254 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000254 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:9A89F0CE3754B0A23F5E7DF5E4712ABC04D69B7E
|texte= Cognitive impairment in nondemented Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |